USPTO serial 87590312
XCELL PRP BY APEX BIOLOGIX
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 4, 2018
- Examiner
- BULLOFF, TOBY ELLEN
- Law office
- Historical data usage
What this means
Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.
Need help with XCELL PRP BY APEX BIOLOGIX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Ian D. Gates
Ian D. Gates Kolitch Romano Dascenzo Gates LLC621 SW Morrison Street #1100Portland, OR 97205United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 010 | Blood containers for medical purposes; Blood component separation apparatus for medical purposes; Blood drawing apparatus; Blood filters; Blood testing apparatus, namely, blood collecting tubes; Blood tubing sets for medical purposes; [ Medical gloves; ] Medical syringes; Sterile sheets, surgical; Apparatus for taking blood; Apparatus for the regeneration of stem cells for medical purposes; Blood collection kit comprised of blood collection bag, holder for medical sample tubes and vials, and medical sample tubes and vials; Filters for blood and blood components for medical purposes; Medical specimen collection devices in the nature of tubes for the collection of blood | ACTIVE | Feb 1, 2018 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by APEX BIOLOGIX, INC.
- Other trademarks owned by APEX Biologix
- Other trademarks owned by APEX Biologix
- Other trademarks owned by APEX Biologix
- Other trademarks in Class 010
- Similar marks named XCELL PRP BY APEX BIOLOGIX
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 29, 2025 | NURC | NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED | — |
| Apr 8, 2025 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Apr 8, 2025 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Apr 8, 2025 | C.7C | NEW CERTIFICATE UNDER SECTION 7 - PROCESSED | — |
| Apr 7, 2025 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Nov 26, 2024 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Nov 20, 2024 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Nov 13, 2024 | ES7R | TEAS SECTION 7 REQUEST RECEIVED | — |
| Dec 7, 2023 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Dec 7, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Dec 7, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 7, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Dec 4, 2023 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Dec 4, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 2, 2018 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Nov 1, 2018 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Oct 25, 2018 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Oct 25, 2018 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Oct 1, 2018 | IUAF | USE AMENDMENT FILED | — |
| Oct 1, 2018 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Apr 3, 2018 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Feb 6, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 6, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 17, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 26, 2017 | ALIE | ASSIGNED TO LIE | — |
| Dec 5, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 5, 2017 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Dec 5, 2017 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Dec 5, 2017 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Dec 5, 2017 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Dec 5, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 8, 2017 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Sep 7, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 2, 2017 | NWAP | NEW APPLICATION ENTERED | — |